Did you mean: Michael Houston, PhD, DSC ?
Web Results

www.prnewswire.com/news-releases/phaserx-appoints-michael-houston-phd-vice-president-therapeutics-development-239595901.html

Jan 10, 2014 ... PhaseRx is privately held RNA therapeutics company developing treatments for orphan liver disease. The Company is utilizing its proprietary ...

humanresearchroadmap.nasa.gov/evidence/reports/DCS.pdf

Wyle Science, Technology & Engineering Group. Houston, TX. Joseph P. Dervay, MD. NASA Johnson Space Center, Houston, TX. Michael L. Gernhardt, PhD.

www.childrenslearninginstitute.org/about-cli/faculty-staff/michael-a-assel-phd

Michael A. Assel, Ph.D., is a Clinical Professor of Pediatrics in the Children's Learning Institute at the University of Texas Health Science Center at Houston.

www.drmwinters.com

Michael speaks on Houston Matters about retirement and adjusting to the changes. From the HoustonMatters.org website. Adjusting to retirement can be a  ...

www.uth.edu/media/story.htm?id=4c976183-5fdf-4a67-85e7-1b42b7d34521

HOUSTON – (Jan. 5, 2016) – Michael R. Blackburn, Ph.D., a nationally recognized lung disease researcher and academic leader, has been appointed ...

www.uh.edu/class/communication/faculty-staff/faculty/MichaelRyan

Michael Ryan, a professor of communication at the University of Houston, has taught media writing, research methods, communication theory, public relations,  ...

www.hms.harvard.edu/dms/neuroscience/development/documents/EnrollmentHistoryofPiN_000.pdf

Allison Doupe, M.D./Ph.D. DCS, B.Sc., McGill University ... Michael Shepley, M.D. /Ph.D. B.S., Northeastern ... E. Houston Warren, Ph.D. A.B., Harvard College.

artsandsciences.sc.edu/geog/hvri/alumni-0

M.S. 2004. Program Manager for the Houston Regional Prepardness Initiative, Houston, TX ... Kevin Borden. Ph.D. 2008, M.S. 2004 ... Ph.D. 1998. DCS Corporation, Huntsville, AL ... M.S. 2000. Michael Baker Corporation, Washington D.C. ...

faculty.mdanderson.org/Michael_Davies

2001, The University of Texas Health Science Center, Houston, TX, MD, PhD, ...... the MHC class 1 cytoplasmic tail to control tumor Ag presentation by DCs.